🔎 Trials Near Me

Gara Jalqabaatti › IGA Glomerulonephritis

Qorannoo klinikaalii IGA Glomerulonephritis Ameerikaa Keessatti hirmaatuu

Qorannoo 19 IGA Glomerulonephritis f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04557462

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06419205

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06935357

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07541287

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 18 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07498335

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 18 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06994845

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06989359

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06858319

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07146906

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06466135

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 18 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07024563

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06797518

Atacicept in Multiple Glomerular Diseases

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06983028

Study of BHV-1400 in IgA Nephropathy

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07054684

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 17 · Saalaa hunda · Haaromfame 12-Cam-2026 · NCT05003986

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Onk-2025 · NCT06676579

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2025 · NCT06952426

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 06-Elb-2025 · NCT06740526

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Elb-2025 · NCT01802034

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.